SA
VCYT icon

Scarborough Advisors’s Veracyte VCYT Stock Holding History

Scarborough Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$3.22K – 666
2026
Q1 		$3.22K Hold
100
– – ﹤0.01% 558
2025
Q4 		$4.21K Hold
100
– – ﹤0.01% 326
2025
Q3 		$3.43K Hold
100
– – ﹤0.01% 330
2025
Q2 		$2.7K Buy
+100
New +$2.9K ﹤0.01% 334

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Scarborough Advisors's VCYT Position: Q2 2026 in Review

Scarborough Advisors sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 100 shares — an estimated $3.22K sold.

Scarborough Advisors first reported a position in VCYT in Q2 2025 and held it in 4 quarters. The position peaked at $4.21K in Q4 2025. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Scarborough Advisors reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 100 Veracyte shares in Q2 2026, an estimated $3.22K.
  • Scarborough Advisors first reported a position in Veracyte in Q2 2025 and held it in 4 quarters.
  • Scarborough Advisors's Veracyte position peaked at $4.21K in Q4 2025.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.